GILPIN WEALTH MANAGEMENT, LLC
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 2058144
DENVER, CO
Position in SUPN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$372
-$144 QoQ
Shares Held
8
-20.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#316
of 331 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GILPIN WEALTH MANAGEMENT, LLC holds $10,344 across 13 Drug Manufacturers - Specialty & Generic names. SUPN ranks #6 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
105 | $3,557 | |
| 2 | ZTS |
Zoetis Inc.
|
34 | $2,443 | |
| 3 | ALKS |
Alkermes plc.
|
30 | $1,571 | |
| 4 | LQDA |
Liquidia Corp
|
9 | $717 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
11 | $451 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
8 | $372 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
|
9 | $228 | |
| 8 | PRGO |
PERRIGO Co plc
|
20 | $207 |
All Filings in SUPN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $372 | 8 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $516 | 10 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $248 | 5 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||